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Ilia Gur, MD,a William Lee, MD,b Gabriel Akopian, MD,a Vincent L. Rowe, MD,b Fred A. Weaver,
MD,b and Steven G. Katz, MD,b Pasadena and Los Angeles, Calif
Objective: While the influence of initial TransAtlantic InterSociety Consensus (TASC) II classification has been clearly
shown to influence the primary patency of infrainguinal stenting procedures, its effect on outcomes once stent failure has
occurred is less well documented. It is the objective of this paper to determine whether clinical outcomes and implications
of anatomic stent failure vary according to initial TASC II classification.
Methods: Results were analyzed by TASC II classification. Kaplan-Meier survival curves were plotted and differences
between groups tested by log-rank method. A Cox proportional hazards regression model was used to perform the
multivariate analysis.
Results: During a 5-year period, 239 angioplasties and stents were performed in 192 patients. Primary patency was lost
in 69 stented arteries. Failure was due to one or more hemodynamically significant stenoses in 43 patients, and occlusion
in 26 patients. After primary stenting, limbs initially classified as TASC C and D were more likely to fail with occlusion
(P < .0001), require open operation (P  .032), or lose run-off vessels (P  .0034) than those classified as TASC A or
B. In two patients initially classified as TASC C, stent failure changed the level of open operation to a more distal site.
Percutaneous reintervention was performed on 35 limbs. Successful reintervention improved the patency of TASC A and
B lesions to 92%, 85%, and 64% and TASC C and D lesions to 78%, 72%, and 50% at 12, 24, and 36 months, respectively.
Initial TASC classification was highly predictive of first anatomic failure (P< .0001), but it did not predict the durability
of subsequent catheter based reintervention (P  .32). Ten patients with stent failure required operation, and five
underwent amputation; all had failed with occlusion. Overall limb salvage was 89% and peri-procedural mortality was
0.4%.
Conclusions: Following primary stenting of the superficial femoral artery (SFA) and popliteal artery, lesions classified as
TASC C or D are more likely to fail with occlusion, lose run-off vessels, and alter the site of subsequent open operation
than their TASC A and B counterparts. Although these complications are infrequent, they may negatively impact later
attempts at revascularization, and this must be considered when deciding upon the proper treatment strategy for patients
with infrainguinal occlusive disease. ( J Vasc Surg 2011;53:658-67.)
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standard treatment for lower limb ischemia, against which
all other treatment modalities are evaluated.
However, since Gruntzig introduced the modern balloon
angioplasty 30 years ago1 and began themodern era of percuta-
neous treatment of peripheral arterial disease, there have been an
ever-increasing number of angioplasties performed.
Over the past 10 years, angioplasty of infra-inguinal
arterial lesions has in many cases become the initial treat-
ment of choice in treatment of iliac, common femoral, and
superficial femoral artery (SFA) lesions.2-4 Previously, we
reported a 675% increase in number of endovascular pro-
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658edures, and a 57% decrease in open procedures in our
nstitutions over recent years.5
Stents made with nitinol, a nickel-titanium alloy with
hape memory properties, have been increasingly used as an
mportant adjunct in the treatment of infra-inguinal occlu-
ive disease. The proponents of angioplasty with or without
tenting point to the advantage of low procedural morbid-
ty, reduced cost, and speed of recovery. Others have ex-
ressed concerns that stent failure and further attempts to
estore patency may limit subsequent open bypass options.
his could occur by worsening run-off or by altering the
ength of the diseased segment adjacent to the stent,
hereby changing the level of the reconstruction to a more
istal site. It is the purpose of this study to evaluate the
utcomes of failed infra-inguinal stented angioplasties, de-
ermine the success of endovascular reintervention, and to
ssess the effect of stent failure on subsequent open surgical
ntervention.
ETHODS
Following institutional review board approval, the
harts of all patients undergoing angioplasty with primary
itinol stenting of the superficial femoral and popliteal
rteries in a single institution during a 62-month period
ere reviewed. During the period of study, all patients
ndergoing angioplasty were also treated with nitinol
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Volume 53, Number 3 Gur et al 659stenting. Patients having orificial occlusion of the SFA and
patients, with total occlusion of the SFA, popliteal artery
(PA) and proximal tibial vessels had no attempts at percu-
taneous interventions and were preferentially treated surgi-
cally. Patients undergoing treatment using covered stents
were excluded from the analysis. The remaining patients
were included in this study.
Interventions were performed by or under the supervi-
sion of one vascular surgeon (S.G.K.) Data were collected
according to the guidelines set forth by the Society for
Vascular Surgery6,7 and stratified by the second Transatlan-
tic Intersocietal Consensus (TASC) II classification.8 Pa-
tient gender, demographics, presence of comorbidities,
history of smoking, and the use of anticoagulation therapy
were recorded. Indication for intervention, location and
severity of the arterial lesion, size and type of stent de-
ployed, and quality of distal run-off were noted. Run-off at
the tibial level was determined by the number of patent
vessels present, with a maximum of 3 (scored as 0, 1, 2, or
3). Poor distal run-off was defined as the visualization on
angiography of one or no tibial run-off distal to the site of
intervention. Significant loss of a run-off was said to have
occurred if there was a change from good to poor or if a
lone run-off vessel was lost. Complications including sig-
nificant hematoma (those requiring transfusion, operation,
or a change in level of care), clinical myocardial infarction
(substantiated by elevated cardiac enzymes), distal emboli-
zation, amputations, and death were recorded.
Type and number of secondary interventions were
noted. Interventions were performed in an angiography
suite with fixed imaging. Our method of angioplasty and
stenting has been previously described.9 Stents were chosen
on the basis of supply and surgeon preference and are listed
in Table I. When multiple stents were employed, they were
overlapped by 1 centimeter. All patients received a total of
300 mg of clopridigrel and 325 mg of aspirin prior to the
procedure. Seventy-five mg of clopridogrel and 81 mg of
aspirin were maintained for at least 30 days post interven-
tion. Low dose aspirin was continued indefinitely. All pa-
tients received 5000 units of heparin prior to percutaneous
transluminal angioplasty (PTA). Anticoagulation was not
reversed at the conclusion of the procedure. Initial proce-
dural success was considered to have occurred when30%
Table I. Stent types and frequency of use
Stent type
Number
N  239 (%)
Abbott-Xceed 69 (28.8)
Abbott-Absolute 12 (5.1)
Abbott-Xpert 9 (3.7)
Bard-Luminex 11 (4.6)
Bard-Conformexx 4 (1.6)
Cordis-SMART Stent 59 (24.6)
Cordis-Precise 2 (0.8)
Edwards Lifescience-Lifestent 49 (20.5)
EV3-Protégé-Everflex 24 (10)stenosis remained in the treated vessel. fiPatients received duplex scans within 30 days of inter-
ention and at 6-month intervals thereafter. Anatomic fail-
re or loss of primary patency was considered to have
ccurred with vessel occlusion, or when a 50% or greater
estenosis at the previous site of angioplasty and stenting
as noted. A 50% stenosis was said to be present when a
eak systolic velocity of at least 200 cm per second and a 3:1
elocity ratio was seen across the lesion. Assisted patency
as said to have been restored when repeat angioplasty or
tenting was required to maintain patency of stenotic or
ccluded segments of previously stented vessels. Assisted
atency was assessed by the same criteria that were used to
efine loss of primary patency.6,7 Duration of primary and
ssisted patency was recorded and used as our outcome
easures when plotting survival curves.
Clinical failure was defined as recurrent or worsening
laudication symptoms, continued rest pain, nonhealing
lcer, or continuing tissue loss.
Outcomes of all failed interventions were recorded by
ata extraction from outpatient and hospital charts, and
ype of failure (clinical, anatomic, or both) was noted. Any
dditional endovascular or open interventions on affected
imb were recorded, angiograms reviewed, and severity of
estenosis and quality of run-off were recorded. The pre-
ntervention and postfailure arteriograms of patients that
equired bypass following stent failure were examined by
hree attending vascular surgeons in a blinded fashion
S.K., V.R., F.W.). The surgeons were then asked to deter-
ine whether their choice of procedure would have dif-
ered based on the two sets of films. Agreement was reached
y consensus of two out of three.
Demographic and comorbidity data were recorded per
atient, and patency data were calculated on a per limb
asis. Kaplan-Meier life tables were calculated on an intent-
o-treat basis and differences tested by log-rank method.
nivariate analysis was performed on factors thought to
ffect the primary patency of the percutaneous interven-
ion. Comparisons were made between those patients who
ost primary or assisted patency and those who did not
sing Cox proportional hazards model. Factors found to be
ignificant in the univariate analysis were then included in a
tep-wise multivariate Cox proportional hazards regression
odel to determine individual significance in the presence
f other factors. A two-tailed Fisher’s exact test was used to
ompare categorical factors. Statistical significance was as-
umed at a P value of less than .05.
All statistical calculations were performed using PASW
8.0 software (formerly SPSS, Chicago, Ill).
ESULTS
Between January 2004 and May 2009, 317 diagnostic
ngiogramswere performed.Twenty-five patients hadorificial
cclusion of the superficial femoral artery, 30 patients had a
ombination of occlusion of the SFA, popliteal artery, and
roximal tibial vessels, and six patients declined endovascular
nterventions. These patients underwent bypass surgery with-
ut an attempt at percutaneous intervention. Two hundred
fty-nine angioplasties and stenting procedures were per-
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March 2011660 Gur et alformed in 208 patients. Sixteen patients, comprising 17 an-
gioplasties, had no follow-up arterial duplex and were ex-
cluded from the study. The remaining 239 angioplasties with
stent placement were performed on 192 patients. Eighty-nine
patients (46.3%) were male and 103 (53.7%) were female.
Mean age was 75.9 years ( 11 years). Patient risk factors are
listed in Table II. Of the 239 angioplasties included in the
study, 143 (60%) were performed for claudication, 43 (17%)
for rest pain, and 53 (23%) for open ulceration or gangrene.
Range of follow-up was 3 to 1782 days with a mean of 408
days, and median of 333 days.
Treated arterial segments are listed in Table III. Run-
off was classified as good (two and three tibial vessels) in
118 limbs (49.4%) and poor (one or less) in 121 limbs
(50.6%). Fifty-nine lesions were classified as TASC A
(24.7%), 98 were TASC B (41%), 48 TASC C (20%), and
34 TASC D (14.3%).
Overall primary patency rates and assisted patency rates
were 73% and 86% at 12 months, 55% and 75% at 24
months, and 40% and 56% at 36 months, respectively (Fig
1). Primary patency rates for TASC A lesions were 90%,
76%, and 64%; for TASC B, 78%, 65%, and 53%; for TASC
C, 65%, 40%, and 25%; and for TASC D, 55%, 32%, and
18% at 12, 24, and 36 months, respectively. When TASC A
and B lesions were compared with TASC C and D, the
primary patency rates at 12, 24, and 36 months were 84%,
70%, and 55% for TASC A and B lesions and 60%, 37%, and
22% for TASC C and D lesions, respectively (Fig 2). The
standard error for calculated Kaplan-Meier curves remained
Table II. Associated risk factors
Risk factors
Number of patients
(n  192) %
Coronary artery disease 130 67.7
Hypertension 177 92
Diabetes 87 45.3
Hypercholesterolemia 98 51
Chronic obstructive
pulmonary disease
38 19.8
End-stage renal disease 13 6.77
Active smokers 55 28.6
Warfarin anticoagulation 9 4.68
Table III. Segments of the infra-inguinal vessel treated
Treated arterial segment
Number of limbs
(n  239) %
Common femoral 12 5
Superficial femoral 107 44.8
Above knee popliteal 29 12.1
Below knee popliteal 8 3.3
Above and below knee popliteal 4 1.67
Common femoral, superficial
femoral and popliteal
2 0.83
Superficial femoral and above
knee popliteal
77 32.210% at 36-month follow-up. This difference between the two groups when compared by log rank method was highly
ignificant (P  .0001).
In univariate analysis, history of hypercholesterolemia,
istory of rest pain, and TASC C and D classifications
egatively impacted the primary patency of the interven-
ions (Table IV). In multivariate analysis (Table V), only
istory of hypercholesterolemia and TASC C and D classi-
cations were found to negatively impact initial stent pa-
ency. The initial TASC classification did not affect stent
atency following repeat intervention (P  .32) at a mean
ollow-up of 356 days after the reintervention. None of the
tudied risk factors was able to predict failure following
econdary intervention.
Primary patency was lost in 69 stented arteries. All
ailures occurred in the superficial femoral and popliteal
rteries. The 12 stents placed in the common femoral artery
emained patent at a mean follow-up of 317 days. The
ailure was due to hemodynamically significant stenosis in
3 cases and due to occlusions in 26 cases. The relative
roportions of failed stents for each TASC classification are
resented in Table VI. No percutaneous reinterventions
ere performed on 34 of the 69 patients with failed stents.
f these, there were four classified as TASC A, eight as
ASC B, 14 as TASC C, and eight as TASC D. Twenty
atients had intra-stent stenosis, nine had stent occlusion,
nd seven initially had intra-stent stenosis, and later devel-
ped complete occlusion per arterial duplex. Of these 34
atients, 10 had no symptoms, nine had stable non-
isabling claudication, seven were lost to further follow-up
ollowing stent failure, and one patient declined repeat
ntervention. Five patients had tissue loss, and two had rest
ain. Of these seven patients, six underwent open bypass
or limb salvage rather than repeat percutaneous interven-
ion. One underwent amputation without repeated at-
empt at revascularization.
Percutaneous reinterventions were performed on 35
imbs of 69 limbs that lost primary patency: 22 under-
ent balloon angioplasty alone for intra-stent stenosis,
nd nine angioplasties were performed for stent occlu-
ion. Of those presenting with occlusion, six had ante-
edent duplex scans demonstrating a hemodynamically
ignificant, but asymptomatic stenosis. One limb re-
uired two reinterventions, the first for stenosis and the
econd for a subsequent occlusion. Three patients re-
uired repeat angioplasty and stenting to treat stent
ractures. Successful reintervention improved patency of
ASC A and B lesions to 92%, 85%, and 64% and TASC
and D lesions to 78%, 72%, and 50% at 12, 24, and 36
onths, respectively (Fig 3). The significant change in
he number of run-off tibial vessels after failed primary
tenting and reintervention as documented by repeat
rteriography was as follows: In the 25 limbs that failed
ith intra-stent stenosis, 21 had unchanged run-off, and
n four the run-off worsened. In the 10 limbs where stent
cclusion occurred, the run-off was unchanged in five
nd worsened in the remaining five. In 34 patients with
ailed primary stenting without subsequent reinterven-
ion, the significant change in run-off as determined by
JOURNAL OF VASCULAR SURGERY
Volume 53, Number 3 Gur et al 661Fig 1. A, Overall primary patency. B, Overall assisted patency.
Months 0 10 20 30 40
Number at risk 239 126 60 33 12Overall assisted patency of all stented segments. Standard error did not exceed 10% at 40 months of follow-up.
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March 2011662 Gur et alduplex scan (27 patients) or angiography (seven pa-
tients) was unchanged in 29 limbs, and worsened in the
remaining five. Of the 15 patients whose run-off wors-
ened, one was initially classified as TASC A, three were
classified as TASC B, seven as TASC C, and four as TASC
D. All had presented with limb threatening ischemia
before their percutaneous intervention. Patients initially
classified as TASC C and D were more likely to lose
run-off vessels following stenting than patients classified
as TASC A or B and were more likely to fail with
occlusion rather than stenosis. Patients failing with oc-
clusion were more likely to lose run-off vessels than those
that failed with stenosis (Table VII). In addition to the
15 patients who lost tibial run-off presumably on the
basis of distal embolization, two patients had occlusion
of a contiguous segment of a popliteal artery at the time
of stent failure.
Fourteen open revascularizations were performed on
Fig 2. Primary patency gro
Months 0 10
Number at risk
TASC A, B
157 69
Number at risk
TASC C, D
82 37
TASC, TransAtlantic InterSociety Consensus.
Primary patency survival curve for TASC A and B vs. C and D. Sta
test P  .0001.these 239 limbs. rTen bypass operations were performed for limb salvage
fter stent failure, and four were performed on limbs with
atent proximal stents and pre-existent disease at a more
istal level. In the 10 patients undergoing open revascular-
zation following stent failure, run-off vessels had been
ompromised by the previous percutaneous intervention in
wo patients.
In the 10 limbs with failed stents in which bypass was
erformed none was initially classified as TASC A, three were
ASC B, two were TASC C, and five were TASCD. Patients
nitially categorized as TASC C and D were more likely to
equire open operation than their TASCA andB counterparts
Table VII). All patients undergoing operation after stent
ailure had failed with occlusion. When the angiograms were
eviewed by the panel of blinded vascular surgeons, it was felt
hat the operative procedure would have changed in two
atients. In both it was felt that the optimal distal site of the
by TASC A, B versus C, D.
20 30 40
27 12 4
16 7 1
d error did not exceed 10% at 40 months of follow-up. Log-rankuped
ndareconstruction had migrated from the above- to the below-
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Volume 53, Number 3 Gur et al 663knee popliteal artery without change in the number of run-off
vessels. Both of these patients later required below knee am-
putation (BKA) following bypass graft occlusion.
There were 11 major amputations performed in our
study population. All of these patients initially presented
with critical limb ischemia. Six amputations were per-
formed on patients with patent stents but with progressive
tissue loss or uncontrolled wound sepsis, and five amputa-
tions were performed on the patients with failed stents. In
the five patients with failed stents, all had failed with occlu-
sion, and run-off had been significantly compromised in
one patient. At the time of initial presentation, one limb
had been classified as TASC C, and four had been classified
as TASC D. Three amputations followed failed open revas-
cularizations that had been performed following stent fail-
ure. Limb salvage in patients with critical limb ischemia was
89%. Following angioplasty and stenting, six patients
Table IV. Risk factors: Univariate analysis
Univariate Cox proportional hazards model
Variable
Hazard ratio
(95% confidence interval) P value
Age 1.003 (0.981-1.026) .798
Female gender 1.527 (0.934-2.496) .091
Coronary artery disease 0.641 (0.397-1.036) .069
Diabetes mellitus 0.898 (0.552-1.436) .667
Hypertension 0.916 (0.368-2.282) .851
Hypercholesterolemia 1.299 (0.809-2.088) .032
Chronic obstructive
pulmonary disease
0.835 (0.457-1.527) .559
Chronic renal failure 0.635 (0.231-1.746) .379
Active smoking 0.874 (0.523-1.469) .606
Indication
Claudication Ref
Rest pain 2.22 (1.119-4.109) .011
Tissue loss 1.564 (0.832-2.939) .164
Run-off score
3 vessels Ref
2 vessels 0.901 (0.474-1.712) .75
1 vessel 0.679 (0.368-1.252) .215
0 vessel 1.2 (0.403-3.577) .743
TransAtlantic InterSociety
Consensus
A and B Ref
C and D 2.861 (1.764-4.642) .0001
Table V. Risk factors: Multivariate analysis
Multivariate Cox regression analysis using backward LR model
Variable
Hazard ratio
(95% confidence interval) P value
Female sex 1.521 (0.929-2.493) .096
Coronary artery disease 0.566 (0.328-0.875) .013
Hypercholesterolemia 1.738 (1.062-2.846) .028
Chronic renal failure 0.441 (0.158-1.231) .118
TransAtlantic InterSociety
Consensus C and D
3.127 (1.910-5.122) .0001(2.5%) developed significant hematomas, two patients suf- dered clinical myocardial infarctions (0.8%), and one patient
0.4%) experienced a distal embolus requiring thromboly-
is. There was one peri-procedural death in this series,
hich resulted from a myocardial infarction three weeks
ost angioplasty and stenting.
ISCUSSION
Lower extremity arterial disease can lead to significant
orbidity, and with our aging population, it can be ex-
ected to place an increasing burden on our health care
ystem. Traditionally, open surgical revascularization has
een employed as the treatment of choice when interven-
ion has been required to treat patients with infrainguinal
cclusive disease. In many institutions, angioplasty and
tenting has been increasingly used as the first line treat-
ent for patients with significant femoropopliteal disease.
he low morbidity, decreased convalescence, and high
atient acceptance make catheter-based procedures attrac-
ive.10-14 However, in many instances they have not proved
o be as durable as open interventions. It is therefore
mportant to critically evaluate the consequences of failed
nfrainguinal angioplasty and stenting.
Initial TASC classification plays a very significant role in
etermining the durability of angioplasty and stenting of
he femoral and popliteal arteries.9 While the primary pa-
ency of these interventions has proved to be long lasting in
ASC A and B lesions, the same cannot be said in those
lassified as TASC C or D.15-17 Primary patency is a strin-
ent measurement tool and allows for excellent compari-
ons of various procedures since it is not influenced by
hysician bias. However, its use as the only tool in evaluat-
ng the worth of an intervention may be misleading. Unless
he consequences of primary failure are analyzed, the true
orth of a procedure cannot be accurately determined.
Following loss of primary patency, a number of patients
equired no further intervention. Some with open ulcer-
tions and limited gangrene were able to heal their lesions
r successfully undergo local amputations before failure of
heir intervention occurred. Others remained with im-
roved symptoms of claudication when anatomic failure
id not lead to significant hemodynamic compromise. An
dditional number of patients could be successfully revas-
ularized by repeat percutaneous intervention with little
esultant morbidity. The use of repeat angioplasty was able
o significantly improve the patency of TASC C and D
esions as well as those initially classified as TASC A or B. It
s interesting to note that while initial TASC classification
as highly correlated with primary patency rates, it could
ot be used to judge the durability of secondary percuta-
eous interventions. This may suggest that previously
tented arteries respond to repeat angioplasty in a different
ashion than native vessels. It has also been our observation
hat when TASCD and D lesions fail, they often do so over
short segment rather than over the entirety of the stented
rea.
When evaluating angioplasty and stenting, it is impor-
ant to consider not only the initial durability of the proce-
ure but the effect that its failure will have on further
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March 2011664 Gur et alattempts at revascularization. Poor arterial run-off has been
reported to negatively impact the patency of infrainginal
bypass grafts and arterial segments treated with angioplasty
alone.18 The effect of run-off on stented vessels has not
been as clear-cut.19-22 While others have reported an asso-
ciation between run-off and stent patency, we were not able
to confirm this finding.9 Nevertheless, it is clear that a
Table VI. Distribution of failed stents by TransAtlantic In
TransAtlantic
InterSociety consensus
Average length of
stented segment (mm)
Ave
of
A 49
B 90
C 193
D 207
A  B
C  D
Fig 3. Assisted patency g
Months 0 10
Number at risk
TASC A, B
157 77
Number at risk
TASC C, D
82 48
TASC, TransAtlantic InterSociety Consensus.
Survival curve of assisted patency for TASC A and B versus C and
P  .007.decrease in the number of tibial run-off vessels could influ- tnce the success of later attempts at revascularization. In
ur series, 22% of the limbs that lost primary patency also
aw a significant deterioration in their tibial vessel run-off.
imbs initially classified as TASC C or D that later failed
ere significantly more likely to suffer a degradation in
un-off following stenting then those initially classified as
ASC A or B. In addition, limbs were more likely to lose
ciety Consensus
number
placed
Did not
fail
Failed with
stenosis
Failed with
occlusion
8 51 7 1
2 79 12 7
9 24 15 9
15 9 9
130 19 8
39 24 18
d by TASC A, B vs C, D.
20 30 40
34 16 5
25 15 6
andard error did not exceed 10% at 40 months. Log-rank testterSo
rage
stents
1.0
1.3
2.2
2.6roupeibial run-off if their stents failed with occlusion rather than
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Volume 53, Number 3 Gur et al 665stenosis. It is interesting to note that 13 of the 26 limbs in
our series that failed with occlusion had an antecedent
asymptomatic stenosis.We have recently beenmore aggres-
sive in treating asymptomatic stenoses, but our follow-up
has not been long enough to determine whether this will
prove to be an effective strategy.
The results reported in the literature regarding bypass
grafting following failure of infrainguinal angioplasty and
stenting have been conflicted. While some have reported
significant compromise in the patency of bypass grafts as
secondary procedures after failed PTA, others have not
demonstrated similar poor outcomes.19-24 In our series, 14
patients required open bypass procedures. In four, stenting
of proximal lesions was used as a prelude to more distal
bypass. In all of these cases, stents remained patent with
normal hemodynamics. In the remaining 10 limbs treated
with open reconstruction, seven remain patent (mean, 21
months). All three patients with graft occlusion later re-
quired BKA. One patient was initially classified as TASC C,
and two were TASC D. One patient lost a solitary run-off
vessel following stent failure requiring bypass to an isolated
popliteal artery segment. The other two patients had the
distal site of their bypass target vessel altered when stent
failure led to occlusion of a previously patent above-knee
popliteal artery. It would appear that in these three patients
the antecedent stenting procedures that caused degrada-
tion of run-off and alteration of the distal target site may
have significantly contributed to subsequent graft failure
and amputation. These results would seem to support the
findings of the recently concluded Bypass vs Angioplasty in
Severe Ischaemia of the Leg (BASIL) study.25 Currently,
we are inclined to employ bypass surgery as the primary
therapeutic intervention in TASCDpatients, provided they
have adequate venous conduit and a life expectancy of 2
years. We occasionally make exceptions and opt for stenting
in poor risk patients who may need a less durable recon-
struction to allow healing of an ulcer or a local amputation.
Many of the amputations in our series were performed
in the face of patent stents. In two patients, angioplasty and
stenting of the SFA were performed to allow healing of a
BKA. In an additional three patients with dialysis depen-
dent renal failure, hemodynamically normal stented arterial
segments were insufficient to allow healing of local ampu-
tations necessitating later BKA. One patient developed
Table VII. Outcomes of stent failure according to TASC
TASC A, B
(n  157)
TASC C, D
(n  82) P value
Stent failure 27 42 .0001
Loss of run-off vessels 4 11 .0032
Stent failed with
occlusion
8 18 .0001
Required open
revascularization
3 7 .0344
TASC, TransAtlantic InterSociety Consensus.overwhelming foot sepsis and required guillotine amputa-ion in the face of patent stents. The remaining five ampu-
ations followed stent failure. As previously described, three
ad undergone arterial bypass grafting that subsequently
ailed. The remaining twowere deemed poor candidates for
pen operation and underwent amputation without at-
empts at revascularization. Our overall limb salvage rate in
hose with critical ischemia was 89%, which is similar to
hose reported by others and does include those salvaged by
ubsequent bypass. We do acknowledge that the exclusion
f patients with flush SFA occlusion and a combination of
cclusion of SFA, popliteal artery, and tibial vessels may
ave influenced our data and recognize that this is a limi-
ation of the study.
We conclude that angioplasty and primary stentingmay
e a reasonable first-line treatment strategy for the majority
f patients with infrainguinal occlusive disease. It carries
inimal patient morbidity and a very low mortality. When
atients with extensive disease and occlusion of the super-
cial femoral, popliteal, and proximal tibial vessels or those
ith flush SFA occlusions are preferentially treated with
urgery, acceptable assisted patency rates after stenting can
e achieved even in patients with TASC C and D lesions.
owever, while patients with TASC A or B lesions under-
oing angioplasty and stenting rarely suffer untoward
vents following primary stent failure, the same cannot be
aid for those with TASC C or D disease. Following failure
f primary stenting, lesions classified as TASC C or D are
ore likely to fail with occlusion rather than stenosis,
ose run-off vessels, and extend the length of contiguous
iseased arterial segments than their TASC A or B counter-
arts. Although infrequent, these complications can have
ignificant consequences, and this must be taken into con-
ideration when deciding upon the proper treatment strat-
gy for patients with infrainguinal occlusive disease.
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Dr Michael T. Caps (Honolulu, Hawaii). I would like to
congratulate the authors for a thought-provoking study and a
well-written manuscript and I would like to thank them for early
delivery of the manuscript for my review.
This study attempts to answer the following two questions: 1)
Among patients undergoing femoropopliteal stent placement, is
there an association between preprocedural TASC classification
and stent failure? and 2) Among those suffering stent failure, is
there an association between preprocedural TASC classification
and other outcomes, including the loss of tibial run-off vessels, the
mechanism (stenosis vs occlusion) of stent failure, and the need for
subsequent open revascularization?
The answer to both questions is “yes”. The authors have
demonstrated an association between the preprocedural TASC
classification and femoropopliteal stent failure, consistent with
previously published studies. They found that patients with more
advanced preprocedural TASC lesions were more likely to suffer
stent failure, more likely to lose tibial run-off vessels when they
failed, more likely to occlude than narrow as their mechanism of
failure, more likely to require open revascularization, and when
they required open revascularization, more likely to require mod-
ification of the operative plan to a more distal anastomotic site for
bypass.
So what does this all mean and how should we modify our
approach to our patients as a result of these findings, if at all? A
more fundamental but implicit question the authors appear to be
investigating is whether certain patients with more advanced in-
frainguinal disease are better served by avoiding endovascular
treatment altogether and proceeding directly to open revascular-mong TASC C and D patients with long-term follow up and
ssessment of clinical as well as anatomic outcomes. Since high
uality studies of this type are not available, we are forced to try to
lean as much information as we can from well-conducted obser-
ational studies such as this one.
I have the following questions for the authors:
. In the manuscript, you state that in your practice, patients with
orificial SFA occlusion and total SFA/popliteal/proximal tibial
occlusion are treated with surgery. As a result of your study,
which other patient populations with femoropopliteal occlusive
disease do you feel should go directly to surgery? Are there
certain types of TASC C/D patients that should go directly to
surgery? Patients with long occlusions and limited run-off?
Patients with long SFA and above-knee popliteal occlusion
whom you risk converting from a femoropopliteal bypass to a
femorotibial bypass? Those with more extensive tissue damage
in the foot? Others?
. What do you believe is the mechanism of tibial artery occlusion
in the patients who suffered stent failure? You suggest a com-
mon mechanism may be thromboembolism occurring at the
time of stent occlusion, yet there are other potential causes.
Patients with long SFA/popliteal occlusions who are recana-
lized are more likely to embolize during the recanalization.
Could they have lost tibial arteries during the initial stenting
procedure? Patients with TASC C/D lesions may also have
more virulent atherosclerosis and may be more prone to de-
velop atherosclerosis disease progression. Is it possible these
patients would have suffered progressive loss of tibials over time
even if they hadn’t been stented?. The strong association you demonstrated between hypercho-
lesterolemia and stent failure was compelling. In addition to
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Volume 53, Number 3 Gur et al 667plavix and aspirin, do you also place your stented patients on a
statin?
4. What fraction of the stent failures were associated with stent
fractures? There is data suggesting that for TASC C and D
lesions, covered stents such as Viabahnmay perform better than
open-cell nitinol stents, perhaps because they are less prone to
stent fracture, particularly in the distal SFA and popliteal arter-
ies. What types of stents were used in this study and were
particular types of stents and particular stent locations more
prone to failure?
Once again, I would like to congratulate the authors for a
well-done study.
Dr William M. Lee. We would like to thank Dr Caps for his
insightful commentary and review. We will attempt to answer his
questions in order.
It is generally well accepted that patients with TASC C/D
lesions who are of reasonable operative risk and have good conduit
should be considered for open revascularization first. In particular,
since failures in the TASC C/D stents in our analysis were more
likely to be accompanied by loss of run-off, patients with only one
or two patent tibial vessels on initial angiography should be
strongly considered for surgical bypass as initial treatment.
The mechanism of loss of run-off remains unclear. Our
practice is to routinely perform run-off angiography immedi-
ately preceding and immediately after angioplasty and stenting. ws a result, we know that tibial run-off was never lost during the
nitial intervention. We agree that thromboembolism and the
atural progression of atherosclerotic disease are the likely
ulprits. Although we did not include analysis of this, a substan-
ial number of our patient population had arterial duplex exam-
nation confirming unchanged tibial run-off in the months prior
o loss of patency, and change in run-off only in conjunction
ith a change in patency. Whether this represents emboli from
he stent occlusion causing a loss of tibial vessels, or perhaps a
atural worsening of the run-off causing patency problems in
he stent is unknown.
Indeed, risk factor modification and pharmacotherapy remain
ainstays of noninterventional treatment. We consider statin ther-
py a vital component of the medical treatment for atherosclerotic
cclusive vascular disease, and work with the referring physicians to
nsure that all patients are adequately treated.
Only three stent fractures in our series were seen, and all were
ssociated with Luminex stents used early in our experience.We no
onger employ these stents in our practice. We have begun incor-
orating the use of the Viabahn stent graft, particularly for long
egment occlusions, but intentionally excluded them from this
eries. When our experience becomes large enough, we hope to
erform a comparative review of those outcomes as well. We were
ot able to define any particular type of stent or stent location that
as more prone to failure.
